Asthma Mucus-Buster trial halted early
NCT ID NCT03822637
Summary
This study tested whether a mucus-thinning drug called NAC could improve breathing in adults with moderate-to-severe asthma who had visible mucus plugs in their lungs on CT scans. Participants received either NAC or a placebo for two weeks, then switched. The trial was terminated early after enrolling only 4 people, so no clear results are available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSF Airway Clinical Research Center
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.